Skip to main content
Clinical Trials/CTRI/2022/03/040862
CTRI/2022/03/040862
Not yet recruiting
Phase 1

A Single arm clinical study to assess efficacy of Dadimadi Ghruta as an add on therapy in chemotherapy induced anemia

Dr Komal Shriram Indulkar0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: D638- Anemia in other chronic diseases classified elsewhere
Sponsor
Dr Komal Shriram Indulkar
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Komal Shriram Indulkar

Eligibility Criteria

Inclusion Criteria

  • Post Chemotherapy patients on hematinic for one month without significant change in hemoglobin level
  • hemoglobin in female less than 12 gm/dl
  • hemoglobin in male less than 13\.5 gm/dl

Exclusion Criteria

  • Patients contra indicated for snehapana
  • Patients having thalassemia, sickle cell anemia and leukemia
  • Patients with low hemoglobin levels before chemotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials